Cohen Matthew Gregory — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Cohen Matthew Gregory has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Matthew Gregory Cohen is listed in SEC filings as a Director of Arrowhead Pharmaceuticals, Inc. as of June 18, 2026. Public biographical information beyond his board directorship is not readily available in major public sources. Arrowhead Pharmaceuticals is a clinical-stage biopharmaceutical company focused on RNA interference (RNAi) therapies. In his capacity as a director, Cohen participates in governance, strategic oversight, and fiduciary duties for Arrowhead. There is no public record in the provided context indicating he is deceased; details about his prior roles or background are not disclosed in the SEC filing context provided.
Role
Director
Notability
60/100
Board memberships
Arrowhead Pharmaceuticals, Inc.
Awards & honors
Director of Arrowhead Pharmaceuticals, Inc. as of 2026-06-18
Matthew Gregory Cohen is listed in SEC filings as a Director of Arrowhead Pharmaceuticals, Inc. as of June 18, 2026. Public biographical information beyond his board directorship is not readily available in major public sources. Arrowhead Pharmaceuticals is a clinical-stage biopharmaceutical company focused on RNA interference (RNAi) therapies. In his capacity as a director, Co…
How many SEC Form 4 filings has Cohen Matthew Gregory submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Cohen Matthew Gregory's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
